Paper3922282
gamma-Vinyl GABA: a double-blind placebo-controlled trial in partial epilepsy.
Gram L and 2 others. Ann Neurol, 1985. Cited by 162 papers, by iCite.
Cite this record
ConductScience Library. gamma-Vinyl GABA: a double-blind placebo-controlled trial in partial epilepsy. Papers, record 3922282. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3922282
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Aminocaproates | Major topic |
| Anticonvulsants | Major topic |
| Epilepsies, Partial | Major topic |
| Adolescent | |
| Adult | |
| Clinical Trials as Topic | |
| Double-Blind Method | |
| Evoked Potentials | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Vigabatrin |
Source PubMed
Cited by31
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 162 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 32730657 | Vigabatrin add-on therapy for drug-resistant focal epilepsy. | Cochrane Database Syst Rev | 2020 | https://conductscience.org/library/papers/32730657 | PubMed |
| 29556176 | Conflicting Effects of Methylglyoxal and Potential Significance of miRNAs for Seizure Treatment. | Front Mol Neurosci | 2018 | https://conductscience.org/library/papers/29556176 | PubMed |
| 25391707 | Drug-induced cerebellar ataxia: a systematic review. | CNS Drugs | 2014 | https://conductscience.org/library/papers/25391707 | PubMed |
| 23683707 | Molecular mechanisms of antiseizure drug activity at GABAA receptors. | Seizure | 2013 | https://conductscience.org/library/papers/23683707 | PubMed |
| 20842588 | New antiepileptic drugs: lacosamide, rufinamide, and vigabatrin. | Curr Treat Options Neurol | 2010 | https://conductscience.org/library/papers/20842588 | PubMed |
| 19851518 | Treatment of refractory complex partial seizures: role of vigabatrin. | Neuropsychiatr Dis Treat | 2009 | https://conductscience.org/library/papers/19851518 | PubMed |
| 11665869 | A risk-benefit assessment of treatments for infantile spasms. | Drug Saf | 2001 | https://conductscience.org/library/papers/11665869 | PubMed |
| 10915031 | Adverse reactions to new anticonvulsant drugs. | Drug Saf | 2000 | https://conductscience.org/library/papers/10915031 | PubMed |
| 10765970 | Visual electrophysiological effect of a GABA transaminase blocker. | Doc Ophthalmol | 1998 | https://conductscience.org/library/papers/10765970 | PubMed |
| 8896946 | Pharmacokinetic interactions of the new antiepileptic drugs. | Clin Pharmacokinet | 1996 | https://conductscience.org/library/papers/8896946 | PubMed |
| 8089668 | Effects of vigabatrin on partial seizures and cognitive function. | J Neurol Neurosurg Psychiatry | 1994 | https://conductscience.org/library/papers/8089668 | PubMed |
| 8037889 | A risk-benefit assessment of vigabatrin in the treatment of neurological disorders. | Drug Saf | 1994 | https://conductscience.org/library/papers/8037889 | PubMed |
| 7917080 | Newer antiepileptic drugs. Towards an improved risk-benefit ratio. | Drug Saf | 1994 | https://conductscience.org/library/papers/7917080 | PubMed |
| 7586896 | The role of therapeutic drug monitoring in improving the cost effectiveness of anticonvulsant therapy. | Clin Pharmacokinet | 1995 | https://conductscience.org/library/papers/7586896 | PubMed |
| 7528126 | Evaluation of antiepileptic drug efficacy. A review of clinical trial design. | Drugs | 1994 | https://conductscience.org/library/papers/7528126 | PubMed |
| 3683730 | Stereoselective uptake of the GABA-transaminase inhibitors gamma-vinyl GABA and gamma-acetylenic GABA into neurons and astrocytes. | Neurochem Res | 1986 | https://conductscience.org/library/papers/3683730 | PubMed |
| 3358887 | Inhibition of the enzyme, GABA-aminotransferase in human platelets by vigabatrin, a potential antiepileptic drug. | Br J Clin Pharmacol | 1988 | https://conductscience.org/library/papers/3358887 | PubMed |
| 2757901 | Vigabatrin in the treatment of epilepsy in children. | Br J Clin Pharmacol | 1989 | https://conductscience.org/library/papers/2757901 | PubMed |
| 2667606 | A multicentre study of vigabatrin for drug-resistant epilepsy. | Br J Clin Pharmacol | 1989 | https://conductscience.org/library/papers/2667606 | PubMed |
| 2667603 | Response to vigabatrin in relation to seizure type. | Br J Clin Pharmacol | 1989 | https://conductscience.org/library/papers/2667603 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ABAT | 18 | PubTator's text mining | https://conductscience.org/library/genes/18 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3922282
GET https://conductscience.org/api/papers/v1/3922282/cited_by?page=2